help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wani, M. R.
Right arrow Articles by Chambers, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wani, M. R.
Right arrow Articles by Chambers, T.
Endocrinology Vol. 140, No. 4 1927-1935
Copyright © 1999 by The Endocrine Society

ARTICLES

Prostaglandin E2 Cooperates with TRANCE in Osteoclast Induction from Hemopoietic Precursors: Synergistic Activation of Differentiation, Cell Spreading, and Fusion

Mohan R. Wani, Karen Fuller, Nack Sung Kim, Yongwon Choi and Tim Chambers

St. George’s Hospital Medical School, London, United Kingdom SW17 ORE; The Rockefeller University (N.S.K., Y.C.), New York, New York 10021; and Howard Hughes Medical Institute (Y.C.), New York, New York 10021

Address all correspondence and requests for reprints to: Dr. T. J. Chambers, Department of Experimental Pathology, St. George’s Hospital Medical School, Cranmer Terrace, London, United Kingdom SW17 ORE. E-mail: t.chambers{at}sghms.ac.uk

It was recently found that osteoblastic cells express TRANCE (tumor necrosis factor-related activation-induced cytokine), a newly identified member of the tumor necrosis factor superfamily, and that expression was increased by calciotropic hormones. Furthermore, soluble recombinant TRANCE induces osteoclast formation and resorption in stroma-free populations of hemopoietic precursor cells. However, overexpression of the decoy receptor osteoprotegerin in vivo shows that there are substantial differences in the sensitivity of different sites to resorption-inhibition, suggesting that either alternative ligands exist or the sensitivity of osteoclasts to TRANCE can be modified by cofactors. We therefore tested the possibility that cofactors might enhance osteoclast formation by TRANCE. We found that the number of tartrate-resistant acid phosphatase-positive and calcitonin receptor-positive cells was increased by a factor of 10 by the presence of PGE2 in the absence of stromal cells. Moreover, although the tartrate-resistant acid phosphatase-positive cells that formed in TRANCE alone were typically mononuclear and poorly spread, the addition of PGE2 induced the formation of large, well spread multinuclear cells. There was an increase in bone resorption that corresponded with the increase in osteoclast number. PGE2 did not synergize with TRANCE for resorption-stimulation in mature cells. 8-Bromo-cAMP showed a similar syngergistic effect on osteoclastic differentiation. Thus, PGE2 appears to stimulate bone resorption through a direct effect on hemopoietic precursors, primarily through a synergistic effect on the ability of TRANCE to induce osteoclastic differentiation.




This article has been cited by other articles:


Home page
 Mol. Endocrinol.Home page
R. D. Nerenz, M. L. Martowicz, and J. W. Pike
An Enhancer 20 Kilobases Upstream of the Human Receptor Activator of Nuclear Factor-{kappa}B Ligand Gene Mediates Dominant Activation by 1,25-Dihydroxyvitamin D3
Mol. Endocrinol., May 1, 2008; 22(5): 1044 - 1056.
[Abstract] [Full Text] [PDF]

Home page
 J. Dent. Res.Home page
H. Oka, M. Miyauchi, K. Sakamoto, S. Moriwaki, S. Niida, K. Noguchi, M.J. Somerman, and T. Takata
PGE2 Activates Cementoclastogenesis by Cementoblasts via EP4
J. Dent. Res., October 1, 2007; 86(10): 974 - 979.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
S. Kim, M. Yamazaki, N. K. Shevde, and J. W. Pike
Transcriptional Control of Receptor Activator of Nuclear Factor-{kappa}B Ligand by the Protein Kinase A Activator Forskolin and the Transmembrane Glycoprotein 130-Activating Cytokine, Oncostatin M, Is Exerted through Multiple Distal Enhancers
Mol. Endocrinol., January 1, 2007; 21(1): 197 - 214.
[Abstract] [Full Text] [PDF]

Home page
 J. Appl. Physiol.Home page
W. Shen, V. Prisk, Y. Li, W. Foster, and J. Huard
Inhibited skeletal muscle healing in cyclooxygenase-2 gene-deficient mice: the role of PGE2 and PGF2{alpha}
J Appl Physiol, October 1, 2006; 101(4): 1215 - 1221.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
A. Mochizuki, M. Takami, T. Kawawa, R. Suzumoto, T. Sasaki, A. Shiba, H. Tsukasaki, B. Zhao, R. Yasuhara, T. Suzawa, et al.
Identification and Characterization of the Precursors Committed to Osteoclasts Induced by TNF-Related Activation-Induced Cytokine/Receptor Activator of NF-{kappa}B Ligand
J. Immunol., October 1, 2006; 177(7): 4360 - 4368.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. Biol.Home page
S. Kim, M. Yamazaki, L. A. Zella, N. K. Shevde, and J. W. Pike
Activation of Receptor Activator of NF-{kappa}B Ligand Gene Expression by 1,25-Dihydroxyvitamin D3 Is Mediated through Multiple Long-Range Enhancers.
Mol. Cell. Biol., September 1, 2006; 26(17): 6469 - 6486.
[Abstract] [Full Text] [PDF]

Home page
 J. Dent. Res.Home page
M. Yamaguchi, N. Aihara, T. Kojima, and K. Kasai
RANKL Increase in Compressed Periodontal Ligament Cells from Root Resorption.
J. Dent. Res., August 1, 2006; 85(8): 751 - 756.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
K. Fuller, B. Kirstein, and T. J. Chambers
Murine Osteoclast Formation and Function: Differential Regulation by Humoral Agents
Endocrinology, April 1, 2006; 147(4): 1979 - 1985.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
M. Yang, G. Mailhot, C. A. MacKay, A. Mason-Savas, J. Aubin, and P. R. Odgren
Chemokine and chemokine receptor expression during colony stimulating factor-1-induced osteoclast differentiation in the toothless osteopetrotic rat: a key role for CCL9 (MIP-1{gamma}) in osteoclastogenesis in vivo and in vitro
Blood, March 15, 2006; 107(6): 2262 - 2270.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
A. T. Bender and J. A. Beavo
PDE1B2 regulates cGMP and a subset of the phenotypic characteristics acquired upon macrophage differentiation from a monocyte
PNAS, January 10, 2006; 103(2): 460 - 465.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
I. Take, Y. Kobayashi, Y. Yamamoto, H. Tsuboi, T. Ochi, S. Uematsu, N. Okafuji, S. Kurihara, N. Udagawa, and N. Takahashi
Prostaglandin E2 Strongly Inhibits Human Osteoclast Formation
Endocrinology, December 1, 2005; 146(12): 5204 - 5214.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
S. Y. Han, N. K. Lee, K. H. Kim, I. W. Jang, M. Yim, J. H. Kim, W. J. Lee, and S. Y. Lee
Transcriptional induction of cyclooxygenase-2 in osteoclast precursors is involved in RANKL-induced osteoclastogenesis
Blood, August 15, 2005; 106(4): 1240 - 1245.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
L. S. Mangashetti, S. M. Khapli, and M. R. Wani
IL-4 Inhibits Bone-Resorbing Activity of Mature Osteoclasts by Affecting NF-{kappa}B and Ca2+ Signaling
J. Immunol., July 15, 2005; 175(2): 917 - 925.
[Abstract] [Full Text] [PDF]

Home page
 Reproductive SciencesHome page
M. Shaarawy, S. Zaki, A.-M. Ramzi, M. E. Salem, and A. M. El-Minawi
Feto-maternal Bone Remodeling in Normal Pregnancy and Preeclampsia
Reproductive Sciences, July 1, 2005; 12(5): 343 - 348.
[Abstract] [PDF]

Home page
 J. Biol. Chem.Home page
Y. Kobayashi, I. Take, T. Yamashita, T. Mizoguchi, T. Ninomiya, T. Hattori, S. Kurihara, H. Ozawa, N. Udagawa, and N. Takahashi
Prostaglandin E2 Receptors EP2 and EP4 Are Down-regulated during Differentiation of Mouse Osteoclasts from Their Precursors
J. Biol. Chem., June 24, 2005; 280(25): 24035 - 24042.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
Y. Kobayashi, T. Mizoguchi, I. Take, S. Kurihara, N. Udagawa, and N. Takahashi
Prostaglandin E2 Enhances Osteoclastic Differentiation of Precursor Cells through Protein Kinase A-dependent Phosphorylation of TAK1
J. Biol. Chem., March 25, 2005; 280(12): 11395 - 11403.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
S. D. Yogesha, S. M. Khapli, and M. R. Wani
Interleukin-3 and Granulocyte-Macrophage Colony-stimulating Factor Inhibits Tumor Necrosis Factor (TNF)-{alpha}-induced Osteoclast Differentiation by Down-regulation of Expression of TNF Receptors 1 and 2
J. Biol. Chem., March 25, 2005; 280(12): 11759 - 11769.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
J. M. Lean, C. J. Jagger, B. Kirstein, K. Fuller, and T. J. Chambers
Hydrogen Peroxide Is Essential for Estrogen-Deficiency Bone Loss and Osteoclast Formation
Endocrinology, February 1, 2005; 146(2): 728 - 735.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
D. Kamei, K. Yamakawa, Y. Takegoshi, M. Mikami-Nakanishi, Y. Nakatani, S. Oh-ishi, H. Yasui, Y. Azuma, N. Hirasawa, K. Ohuchi, et al.
Reduced Pain Hypersensitivity and Inflammation in Mice Lacking Microsomal Prostaglandin E Synthase-1
J. Biol. Chem., August 6, 2004; 279(32): 33684 - 33695.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
G. D. Roodman
Mechanisms of Bone Metastasis
N. Engl. J. Med., April 15, 2004; 350(16): 1655 - 1664.
[Full Text] [PDF]

Home page
 J. Dent. Res.Home page
J.Y.Y. Tay, B.H. Bay, J.F Yeo, M. Harris, S. Meghji, and S.T. Dheen
Identification of RANKL in Osteolytic Lesions of the Facial Skeleton
J. Dent. Res., April 1, 2004; 83(4): 349 - 353.
[Abstract] [Full Text] [PDF]

Home page
 Crit. Rev. Oral Biol. Med.Home page
U. H. Lerner
NEW MOLECULES IN THE TUMOR NECROSIS FACTOR LIGAND AND RECEPTOR SUPERFAMILIES WITH IMPORTANCE FOR PHYSIOLOGICAL AND PATHOLOGICAL BONE RESORPTION
Crit. Rev. Oral. Biol. Med., March 1, 2004; 15(2): 64 - 81.
[Abstract] [Full Text]

Home page
 EndocrinologyHome page
S.-K. Lee, J. F. Kalinowski, S. L. Jastrzebski, L. Puddington, and J. A. Lorenzo
Interleukin-7 Is a Direct Inhibitor of in Vitro Osteoclastogenesis
Endocrinology, August 1, 2003; 144(8): 3524 - 3531.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
S. M. Khapli, L. S. Mangashetti, S. D. Yogesha, and M. R. Wani
IL-3 Acts Directly on Osteoclast Precursors and Irreversibly Inhibits Receptor Activator of NF-{kappa}B Ligand-Induced Osteoclast Differentiation by Diverting the Cells to Macrophage Lineage
J. Immunol., July 1, 2003; 171(1): 142 - 151.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
S. W. Fox, S. J. Haque, A. C. Lovibond, and T. J. Chambers
The Possible Role of TGF-{beta}-Induced Suppressors of Cytokine Signaling Expression in Osteoclast/Macrophage Lineage Commitment In Vitro
J. Immunol., April 1, 2003; 170(7): 3679 - 3687.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
Y. Tintut, F. Parhami, A. Tsingotjidou, S. Tetradis, M. Territo, and L. L. Demer
8-Isoprostaglandin E2 Enhances Receptor-activated NFkappa B Ligand (RANKL)-dependent Osteoclastic Potential of Marrow Hematopoietic Precursors via the cAMP Pathway
J. Biol. Chem., April 12, 2002; 277(16): 14221 - 14226.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
K. Fuller, C. Murphy, B. Kirstein, S. W. Fox, and T. J. Chambers
TNF{alpha} Potently Activates Osteoclasts, through a Direct Action Independent of and Strongly Synergistic with RANKL
Endocrinology, March 1, 2002; 143(3): 1108 - 1118.
[Abstract] [Full Text] [PDF]

Home page
 Endocr. Rev.Home page
J. Pfeilschifter, R. Koditz, M. Pfohl, and H. Schatz
Changes in Proinflammatory Cytokine Activity after Menopause
Endocr. Rev., February 1, 2002; 23(1): 90 - 119.
[Abstract] [Full Text] [PDF]

Home page
 J. Exp. Med.Home page
N. Kim, M. Takami, J. Rho, R. Josien, and Y. Choi
A Novel Member of the Leukocyte Receptor Complex Regulates Osteoclast Differentiation
J. Exp. Med., January 14, 2002; 195(2): 201 - 209.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
J. M. Lean, K. Fuller, and T. J. Chambers
FLT3 ligand can substitute for macrophage colony-stimulating factor in support of osteoclast differentiation and function
Blood, November 1, 2001; 98(9): 2707 - 2713.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
R. N. Pearse, E. M. Sordillo, S. Yaccoby, B. R. Wong, D. F. Liau, N. Colman, J. Michaeli, J. Epstein, and Y. Choi
Multiple myeloma disrupts the TRANCE/ osteoprotegerin cytokine axis to trigger bone destruction and promote tumor progression
PNAS, September 13, 2001; (2001) 201394498.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
G. D. Roodman
Biology of Osteoclast Activation in Cancer
J. Clin. Oncol., August 1, 2001; 19(15): 3562 - 3571.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
K. Itoh, N. Udagawa, T. Katagiri, S. Iemura, N. Ueno, H. Yasuda, K. Higashio, J. M. W. Quinn, M. T. Gillespie, T. J. Martin, et al.
Bone Morphogenetic Protein 2 Stimulates Osteoclast Differentiation and Survival Supported by Receptor Activator of Nuclear Factor-{kappa}B Ligand
Endocrinology, August 1, 2001; 142(8): 3656 - 3662.
[Abstract] [Full Text] [PDF]

Home page
 Rheumatology (Oxford)Home page
D. R. Haynes, T. N. Crotti, M. Loric, G. I. Bain, G. J. Atkins, and D. M. Findlay
Osteoprotegerin and receptor activator of nuclear factor kappaB ligand (RANKL) regulate osteoclast formation by cells in the human rheumatoid arthritic joint
Rheumatology, June 1, 2001; 40(6): 623 - 630.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
S. W. Fox, K. Fuller, K. E. Bayley, J. M. Lean, and T. J. Chambers
TGF-{beta}1 and IFN-{gamma} Direct Macrophage Activation by TNF-{alpha} to Osteoclastic or Cytocidal Phenotype
J. Immunol., November 1, 2000; 165(9): 4957 - 4963.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
D. Grcevic, S.-K. Lee, A. Marusic, and J. A. Lorenzo
Depletion of CD4 and CD8 T Lymphocytes in Mice In Vivo Enhances 1,25-Dihydroxyvitamin D3-Stimulated Osteoclast-Like Cell Formation In Vitro by a Mechanism That Is Dependent on Prostaglandin Synthesis
J. Immunol., October 15, 2000; 165(8): 4231 - 4238.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
T. Kaneda, T. Nojima, M. Nakagawa, A. Ogasawara, H. Kaneko, T. Sato, H. Mano, M. Kumegawa, and Y. Hakeda
Endogenous Production of TGF-{beta} Is Essential for Osteoclastogenesis Induced by a Combination of Receptor Activator of NF-{kappa}B Ligand and Macrophage-Colony- Stimulating Factor
J. Immunol., October 15, 2000; 165(8): 4254 - 4263.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
L. C. Hofbauer and A. E. Heufelder
The Role of Receptor Activator of Nuclear Factor-{kappa}B Ligand and Osteoprotegerin in the Pathogenesis and Treatment of Metabolic Bone Diseases
J. Clin. Endocrinol. Metab., July 1, 2000; 85(7): 2355 - 2363.
[Full Text]

Home page
 EndocrinologyHome page
X. Li, Y. Okada, C. C. Pilbeam, J. A. Lorenzo, C. R. J. Kennedy, R. M. Breyer, and L. G. Raisz
Knockout of the Murine Prostaglandin EP2 Receptor Impairs Osteoclastogenesis in Vitro
Endocrinology, June 1, 2000; 141(6): 2054 - 2061.
[Abstract] [Full Text] [PDF]

Home page
 Endocr. Rev.Home page
S. C. Manolagas
Birth and Death of Bone Cells: Basic Regulatory Mechanisms and Implications for the Pathogenesis and Treatment of Osteoporosis
Endocr. Rev., April 1, 2000; 21(2): 115 - 137.
[Abstract] [Full Text]

Home page
 J. Cell Sci.Home page
K Fuller, J. Lean, K. Bayley, M. Wani, and T. Chambers
A role for TGFbeta(1) in osteoclast differentiation and survival
J. Cell Sci., January 7, 2000; 113(13): 2445 - 2453.
[Abstract] [PDF]

Home page
 J. Biol. Chem.Home page
P. Collin-Osdoby, L. Rothe, F. Anderson, M. Nelson, W. Maloney, and P. Osdoby
Receptor Activator of NF-kappa B and Osteoprotegerin Expression by Human Microvascular Endothelial Cells, Regulation by Inflammatory Cytokines, and Role in Human Osteoclastogenesis
J. Biol. Chem., June 1, 2001; 276(23): 20659 - 20672.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
J. R. Arron, M. Vologodskaia, B. R. Wong, M. Naramura, N. Kim, H. Gu, and Y. Choi
A Positive Regulatory Role for Cbl Family Proteins in Tumor Necrosis Factor-related Activation-induced Cytokine (TRANCE) and CD40L-mediated Akt Activation
J. Biol. Chem., August 3, 2001; 276(32): 30011 - 30017.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
R. N. Pearse, E. M. Sordillo, S. Yaccoby, B. R. Wong, D. F. Liau, N. Colman, J. Michaeli, J. Epstein, and Y. Choi
Multiple myeloma disrupts the TRANCE/ osteoprotegerin cytokine axis to trigger bone destruction and promote tumor progression
PNAS, September 25, 2001; 98(20): 11581 - 11586.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1999 by The Endocrine Society